<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20170705034914N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-09-30</date_registration>
      <primary_sponsor>Shahroud University of Medical Sciences</primary_sponsor>
      <public_title>The effect of peer education on menopausal symptoms</public_title>
      <acronym></acronym>
      <scientific_title>The effect of peer education on menopausal symptoms in menopausal women</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-10-07</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>120</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/41792</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Other design features: , Randomization description: In this study, the randomization unit will be individual. Block randomization is going to be used for randomization. 120 samples will randomly be divided into control and intervention groups in 30 blocks of 4(Including 2 participants in intervention group and 2 participants in control group), based on the random numbers that will be produced using website https://www.sealedenvelope.com/simple -randomizer. (60 participants in intervention group and 60 participants in control group). 
Using the central method, the allocation sequence will be concealed. The allocation sequence will be performed with the help of researcher assistance 1. At each center, researcher's assistance (2, 3, and 4) will register eligible individuals, and by contacting with the researcher assistance 1, Individuals, as they will be enrolled in the study, will also enter to a central list and   assign to target groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Menopause.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In this study, intervention is going to be performed at two stages. The first stage will be selecting the peer group and educating them and the second stage, performing the intervention. At the stage of selecting the peers, six menopausal women (2 peers from each center), who will have some characteristics such as ability to run educational sessions, willingness to cooperate with the researcher, have appropriate social communications, having at least high school degree and interest in leading the group will be selected by the researcher as the trainers of the peer group. During 4 sessions (2 hours twice a week for duration of 2 week), selected peers who will be educated by the researcher about the importance and advantages of peer education, menopause, menopausal symptom and the methods of confronting and coping with it.Education will be performed using speech, question and answer with the help of learn assist tools (slides, images, etc.). After each educational session is going to be completed, the participants will exercise the trained items in the presence of the researcher using role play method. at the second stage, 60 participants for the peer education group will be divided into six groups of 10 and each of the selected peers will be allocated to educate one of the divisions; educating the peers is going to be performed during 4  educational sessions (2 hours once a week for duration of 4 week ). The intervention group, In addition to services that will be provided in health centers, will receive peer education. Intervention 2: Control group: Sixty menopausal women who will be referred to health centers in the control group will receive no intervention. They will receive only routine services and train is going to be provided at health centers.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Leila Mollaahmadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>1st floor, unit 2, No.122, 206 Eastern Ave., Tehran pars 3rd Sq.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1655716866</zip>
        <telephone>+98 21 7738 0715</telephone>
        <email>ahmadileila49@yahoo.co.uk</email>
        <affiliation>Shahroud University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Leila Mollaahmadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>1st floor,  unit 2, No.122, 206 Eastern Ave., Tehran pars 3rd Sq.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1655716866</zip>
        <telephone>+98 21 7738 0715</telephone>
        <email>ahmadileila49@yahoo.co.uk</email>
        <affiliation>Shahroud University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Having a health record at a health care center
Having at least the elementary school literacy
Being married and having sex
Having symptoms of menopause
At least one year and up to 5 years after menopause
Menopause occurs naturally
Having Iranian nationality
Having mental and physical health
Voluntary participation and written consent</inclusion_criteria>
      <agemin>45 years</agemin>
      <agemax>60 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Treated with hormonal drugs to relieve menopausal symptoms
Being addicted to cigarette. drugs and  alcohol
Having mental, neurological and cancer diseases</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Lifestyle</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In this study, intervention is going to be performed at two stages. The first stage will be selecting the peer group and educating them and the second stage, performing the intervention. At the stage of selecting the peers, six menopausal women (2 peers from each center), who will have some characteristics such as ability to run educational sessions, willingness to cooperate with the researcher, have appropriate social communications, having at least high school degree and interest in leading the group will be selected by the researcher as the trainers of the peer group. During 4 sessions (2 hours twice a week for duration of 2 week), selected peers who will be educated by the researcher about the importance and advantages of peer education, menopause, menopausal symptom and the methods of confronting and coping with it.Education will be performed using speech, question and answer with the help of learn assist tools (slides, images, etc.). After each educational session is going to be completed, the participants will exercise the trained items in the presence of the researcher using role play method. at the second stage, 60 participants for the peer education group will be divided into six groups of 10 and each of the selected peers will be allocated to educate one of the divisions; educating the peers is going to be performed during 4  educational sessions (2 hours once a week for duration of 4 week ). The intervention group, In addition to services that will be provided in health centers, will receive peer education.</i_keyword>
      <i_keyword>Control group: Sixty menopausal women who will be referred to health centers in the control group will receive no intervention. They will receive only routine services and train is going to be provided at health centers</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Vasomotor symptoms. Timepoint: Before the  intervention , immediately after the intervention  and one month after the intervention. Method of measurement: Women's Health Questionnaire (WHQ).</prim_outcome>
      <prim_outcome>Somatic symptoms. Timepoint: Before the  intervention , immediately after the intervention  and one month after the intervention. Method of measurement: Women's Health Questionnaire (WHQ).</prim_outcome>
      <prim_outcome>Sexual problems. Timepoint: Before the  intervention , immediately after the intervention  and one month after the intervention. Method of measurement: Women's Health Questionnaire (WHQ).</prim_outcome>
      <prim_outcome>Anxiety/fear. Timepoint: Before the  intervention , immediately after the intervention  and one month after the intervention. Method of measurement: Women's Health Questionnaire (WHQ).</prim_outcome>
      <prim_outcome>Memory / concentration. Timepoint: Before the intervention , immediately after the intervention  and one month after the intervention. Method of measurement: Women's Health Questionnaire (WHQ).</prim_outcome>
      <prim_outcome>Sleep problems. Timepoint: Before the intervention , immediately after the intervention  and one month after the intervention. Method of measurement: Women's Health Questionnaire (WHQ).</prim_outcome>
      <prim_outcome>Depressed mood. Timepoint: Before the intervention , immediately after the intervention  and one month after the intervention. Method of measurement: Women's Health Questionnaire (WHQ).</prim_outcome>
      <prim_outcome>Attractiveness. Timepoint: Before the intervention , immediately after the intervention  and one month after the intervention. Method of measurement: Women's Health Questionnaire (WHQ).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahroud University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-07-19</approval_date>
        <contact_name>Ethics Committee of Shahroud University of Medical Sciences</contact_name>
        <contact_address>HaftTir  Sq., Central building of Shahroud University of Medical Sciences and Health Services Shahroud Semnan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
